Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.

Ramco Cements, Asahi India Glass and Glenmark Pharmaceuticals shares were among major gainers on Friday.

Divi's Labs and Glenmark shares jumped to 52-week highs and the stocks closed near their highs. On technical charts, both the stocks are looking strong.

Glenmark Pharmaceuticals Shares will be in focus today as the company has announced recall for two products in the US Market.

Market expert Mitesh Thakkar has suggested three BUY Calls and one SELL Call for today’s trading session.

Market expert Mitesh Thakkar has suggested two BUY Calls and two SELL Calls for today’s trading session.